Pfizer other research news

Pfizer (Groton, Conn.) published its use of the GLUT4 receptor as a gene therapy in mice, reporting in the Journal of Clinical Investigation that the strategy boosted insulin responsiveness and corrected blood glucose levels in a mouse model.

The test mice were genetically susceptible to diabetes, but developed with normal levels of blood glucose, and normal responsiveness to insulin, when, as embryos, they were microinjected with the human GLUT4 gene. ...